Association of Visfatin with Blood Glucose, Insulin Resistance and Body Mass Index in Patients with Type ۲ Diabetes/Pre-Diabetes

  • سال انتشار: 1400
  • محل انتشار: مجله علوم پیشرفته زیست پزشکی، دوره: 11، شماره: 3
  • کد COI اختصاصی: JR_JABS-11-3_011
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 105
دانلود فایل این مقاله

نویسندگان

حلما کریمی

Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Science, Tehran Iran

معصومه نژادعلی

Department of Biology, Islamshahr Branch, Islamic Azad University, Islamshahr, Iran

مریم مهدوی

Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مینو ساعتیان

Department of Pathology, Islamic Azad University, Medical Tehran Branch, Tehran, Iran

لیلا سعیدی

Department of Biology, Islamshahr Branch, Islamic Azad University, Islamshahr, Iran

چکیده

Background & Objective: In recent studies visfatin has been introduced as a multifaceted protein that plays a role in pathogenesis of many disorders and disease such as obesity and type ۲ diabetes. The aim of this study was to evaluate the association of visfatin with fasting blood glucose, insulin resistance and body mass index in patients with type ۲ diabetes / impaired fasting glucose (T۲DM, IFG) compared to non-diabetic subjects. Material & Methods: This case control study was performed on ۱۶۰ volunteers. ۸۰ participants were categorized in type ۲ diabetic group holding FBG ≥۱۰۰ (mg/dl) and ۸۰ participants were categorized in non-diabetic (healthy) group holding FBG ۷۰-۱۰۰ (mg/dl). Serum visfatin levels were measured using enzyme-linked immune sorbent assay (ELISA) and HOMA-IR equation was used for insulin sensitivity check. Results: The result was presented as mean+ standard deviation and p< ۰.۰۵ was considered as statistically significant. Diabetic group showed a higher level of age in comparison with the non-diabetics. Meanwhile, the means of TG, FBG, BMI, WC, HC and HOMA were also significantly different between the two groups. Visfatin level was not different between diabetics and normal healthy controls. There was a positive correlation between visfatin and BMI in non-diabetics. Also, in diabetics there was a positive correlation between visfatin and BMI, HDL, Hip, insulin and HOMA-IR and a negative correlation between visfatin and FBG level. Conclusion: Our study showed that there was an association between visfatin and BMI but not with type ۲ diabetes. Also, there was a significant association between this adipokine and insulin resistance in diabetic and pre-diabetic patients which indicates the pathological role of visfatin in insulin resistance.

کلیدواژه ها

Type ۲ diabetes, visfatin, insulin resistance, body mass index, fasting blood glucose

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.